A Phase 1b Study of JNJ-75276617 in Combination with AML Directed Therapies for Participants with Acute Myeloid Leukemia Harboring KMT2A or NPM1 Alterations

  • Fedele, Pasquale (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date30/08/22 → 29/08/27

Keywords

  • phase 1 study
  • treatment safety
  • treatment efficacy
  • leukemia